This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo
Back to library search

Regulatory Compliance in a Multi-National Organization

Abstract

The regulatory environment has changed substantially over the past sixty years. More countries are adopting what at times are conflicting regulatory programs. In addition, communication among regulators has increased. Companies can no longer structure their regulatory compliance programs by focusing on one or two major countries. Counsel today needs to follow a structured approach to evaluating compliance and creating a compliance program. This article suggests key steps to take and identifies some of the major considerations counsel will need to address in this process.

Author

Portrait image of Jack Sorokin
Jack Sorokin
Adjunct Instructor, Fremont College, USA

Jack Sorokin has had extensive experience as regulatory affairs counsel, most recently as Deputy General Counsel for Beckman Coulter, Inc., a leading international manufacturer and marketer of biomedical testing instrument systems, tests and supplies that simplify, automate and innovate complex laboratory processes. His practice has covered the range of regulatory issues, including medical device, environmental, occupational safety and health, hazardous materials, controlled substance, and transportation. His practice has also included corporate law and governance, SEC compliance, finance, risk management, supply chain, manufacturing, real estate, procurement, and import/export law. He retired from Beckman Coulter in June, 2012 and is currently an Instructor in the Fremont College Paralegal Studies Program.

Company

Fremont College

Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. The Company's diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients. Scientists use Beckman Coulter's life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs. More than 275,000 Beckman Coulter systems operate in both diagnostics and life sciences laboratories on six continents

Related Papers

Implementing a Robust Compliance Program in a Remote Environment
Implementing an effective Compliance program can be complicated and challenging in the best of times, especially when you operate globally in a rapidly changing environment. These challenges and complexities have...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Tatiyana Akers
Tatiyana Akers
Associate Director, Compliance, Aimmune Therapeutics, USA
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
Portrait image of Brenda Crabtree
Brenda Crabtree
Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA
Covid19 and the new Role of Legal and Compliance
Lawyers and compliance officer are, basically professionals of the “status quo”. They seek assurance that everyone is performing in accordance with existing laws, regulations, and policies. So, “follow the rules...Read more
Portrait image of Fabio Cunha
Fabio Cunha
General Counsel, Legal and Compliance Director, Dasa, Brazil
What Makes a Great Compliance Leader?
Great leaders exercise emotional intelligence, and they are very adept at understanding their strengths and weaknesses as well as those around them and can assess a situation pretty accurately and...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
Portrait image of Brenda Crabtree
Brenda Crabtree
Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA
Portrait image of undefined
Portrait image of Lisa Mares
Lisa Mares
Executive Assistant, Compliance, Aimmune Therapeutics, Inc., USA
Compliance Red Flags: What Companies Should Look Out For in Times of Change
Although we know that compliance is everyone’s responsibility, we also understand that company personnel are focused on their primary roles and responsibilities, and because of this, compliance requirements may not...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Tatiyana Akers
Tatiyana Akers
Associate Director, Compliance, Aimmune Therapeutics, USA
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
Portrait image of Brenda Crabtree
Brenda Crabtree
Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA